You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hodgkins Lymphona high risk for relapse

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Digital Droplet PCR in Early Period After Allo-HSCT to Predict

Completed
  • Measurable Residual Disease
  • Digital Droplet PCR
  • Hangzhou, Zhejiang, China
    The First Hospital of Zhejiang Medical Colleage Zhejiang Univers
Aug 17, 2023

Identify Resected Non-small-cell Lung Cancer With High Risk of

Recruiting
  • Non-small Cell Lung Cancer Stage IIIA
  • Resected non small cell lung cancer
  • Toulouse, France
    Julien MAZIERES
Feb 8, 2023

Prostatic Tumors Trial in Charleston (PROSTVAC-V/F)

Active, not recruiting
  • Prostatic Neoplasms
  • PROSTVAC-V/F
  • Charleston, South Carolina
    Medical University of South Carolina
Jan 30, 2023

Cancer Colorectal Trial (a multi-locus blood-based assay)

Not yet recruiting
  • Cancer Colorectal
  • a multi-locus blood-based assay
  • (no location specified)
Sep 7, 2022

ACUTE LYMPHOBLASTIC LEUKEMIA Trial (Inotuzumab ozogamicin, ALLR3)

Not yet recruiting
  • ACUTE LYMPHOBLASTIC LEUKEMIA
  • (no location specified)
Feb 17, 2023

NHL, Non Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma Trial in Minneapolis, Saint Louis (FT596, Rituximab)

Suspended
  • NHL
  • +3 more
  • Minneapolis, Minnesota
  • +1 more
Jan 31, 2023

Novel Panels for Early Precision Diagnosis and Relapse

Completed
  • Leukemia, Acute
  • High-risk subtype detection panels
  • Nanjing, Jiangsu, China
    Department of Hematology, Zhongda Hospital Southeast University,
Mar 23, 2022

Clostridium Difficile Trial in Bronx (Bezlotoxumab)

Terminated
Has Results
  • Clostridium Difficile
  • Bronx, New York
    Montefiore Medical Center
Oct 13, 2022

MDS, de Novo, MDS, Secondary, MDS, Previously Treated Trial in Boston (Venetoclax, Azacitidine, Cytarabine)

Recruiting
  • Myelodysplastic Syndromes, de Novo
  • +10 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Jan 23, 2023

Adult Acute Myeloid Leukemia in Remission, Recurrent Adult Acute Myeloid Leukemia Trial in Aurora, Columbus (PF-04449913)

Completed
Has Results
  • Adult Acute Myeloid Leukemia in Remission
  • Recurrent Adult Acute Myeloid Leukemia
  • Aurora, Colorado
  • +1 more
Dec 30, 2021

Acute Myeloid Leukemia, Allogeneic Stem Cell Transplantation Trial (Siremadlin)

Recruiting
  • Acute Myeloid Leukemia
  • Allogeneic Stem Cell Transplantation
  • Tel Aviv, Israel
  • +2 more
Jan 23, 2023

Primary Non-metastatic Breast Cancer, Who Remain Disease-free Trial in Lyon, Villejuif (Everolimus, Placebo)

Active, not recruiting
  • Primary Non-metastatic Breast Cancer
  • Who Remain Disease-free
  • Lyon, France
  • +1 more
Feb 23, 2022

Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult Acute Myeloid Leukemia in Remission, Blasts Under

Active, not recruiting
  • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
  • +3 more
  • Laboratory Biomarker Analysis
  • Nivolumab
  • Houston, Texas
    M D Anderson Cancer Center
Jan 10, 2022

Hematologic Malignancies, Relapse, GVHD Trial in Ann Arbor (Carfilzomib, Tacrolimus)

Completed
Has Results
  • Hematologic Malignancies
  • +2 more
  • Ann Arbor, Michigan
    University of Michigan Hospital
Dec 3, 2021

Neuroblastoma Recurrent Trial in Worldwide (Naxitamab and GM-CSF in combination with irinotecan and temozolomide)

Terminated
  • Neuroblastoma Recurrent
  • Naxitamab and GM-CSF in combination with irinotecan and temozolomide
  • Hong Kong, Hong Kong
  • +2 more
Nov 8, 2022

MDS (MDS), Acute Myelogenous Leukemia (AML) Trial in United States (low dose 5'-azacitidine)

Active, not recruiting
  • Myelodysplastic Syndromes (MDS)
  • Acute Myelogenous Leukemia (AML)
  • low dose 5'-azacitidine
  • Basking Ridge, New Jersey
  • +6 more
Dec 1, 2022

Adenocarcinoma of Prostate, Progression of Prostate Cancer Trial in Villejuif (Cabazitaxel, Pelvic radiotherapy, prostate

Active, not recruiting
  • Adenocarcinoma of Prostate
  • Progression of Prostate Cancer
  • Villejuif, France
    Institut Gustave Roussy
Oct 5, 2021

Breast Tumors Trial in France (MAG-TN3 + AS15)

Completed
  • Breast Neoplasms
  • MAG-TN3 + AS15
  • Lyon, France
  • +4 more
Mar 21, 2022

Acute Myeloid Leukemia Trial in Atlanta (Fludarabine, Melphalan, Pembrolizumab)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Atlanta, Georgia
  • +1 more
Sep 7, 2022

Leukemia, Myeloid, Acute Trial in Guanzhou (Azacitidine, Chidamide)

Recruiting
  • Leukemia, Myeloid, Acute
  • Guanzhou, Guandong, China
    Nanfang Hospital of Southern Medical University
Mar 6, 2022

Hodgkins Lymphoma, Non Hodgkins Lymphoma Trial in Houston (TAA-specific CTLs)

Recruiting
  • Hodgkins Lymphoma
  • Non Hodgkins Lymphoma
  • TAA-specific CTLs
  • Houston, Texas
    Texas Children's Hospital
Jul 14, 2022

Prostate Cancer Trial in France (drug, procedure, radiation)

Completed
  • Prostate Cancer
  • Angers, France
  • +37 more
Jan 17, 2023

Osteosarcoma, Ewing Sarcoma Trial in Bologna (Metformin Hydrochloride)

Recruiting
  • Osteosarcoma
  • Ewing Sarcoma
  • Metformin Hydrochloride
  • Bologna, Italy
    Chemotherapy Div, Istituto Ortopedico Rizzoli
Mar 28, 2021

Pediatric and Young Adult Patientswith Hypodiploid or t(17;19) B-ALL, Infants With Very High Risk KMT2A B-ALL, Patients With CNS

Active, not recruiting
  • Pediatric and Young Adult Patientswith Hypodiploid or t(17;19) B-ALL
  • +2 more
  • Murine CART19
  • Philadelphia, Pennsylvania
    Children's Hospital of Philadelphia
Jan 11, 2022

NSCLC Trial in Shanghai (Camrelizumab, Famitinib)

Not yet recruiting
  • NSCLC
  • Shanghai, Shanghai, China
    Shanghai Chest Hospital
Aug 5, 2021